239 related articles for article (PubMed ID: 2670693)
1. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
[TBL] [Abstract][Full Text] [Related]
2. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
4. Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
Porres JC; Carreño V; Mora I; Gutiez J; Moreno A; Ramon y Cajal S; Marron JA; Bartolomé J
Hepatogastroenterology; 1988 Dec; 35(6):300-3. PubMed ID: 3215626
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
6. Changes in anti-idiotype antibodies against anti-HBs during recombinant interferon treatment of chronic hepatitis B.
Ibarra MZ; Porres JC; Bartolome FJ; Escudero M; Quiroga JA; Carreño V
J Interferon Res; 1990 Aug; 10(4):367-73. PubMed ID: 2230344
[TBL] [Abstract][Full Text] [Related]
7. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
8. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
12. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
13. Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.
Mora I; Porres JC; Bartolomé J; Quiroga JA; Gutiez J; Hernández Guio C; Bas C; Carreño V
J Hepatol; 1987 Feb; 4(1):29-36. PubMed ID: 3571931
[TBL] [Abstract][Full Text] [Related]
14. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
[TBL] [Abstract][Full Text] [Related]
15. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
[TBL] [Abstract][Full Text] [Related]
16. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population.
Wong DK; Yim C; Naylor CD; Chen E; Sherman M; Vas S; Wanless IR; Read S; Li H; Heathcote EJ
Gastroenterology; 1995 Jan; 108(1):165-71. PubMed ID: 7806038
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon.
Thomas HC; Karayiannis P; Brook G
J Hepatol; 1991; 13 Suppl 1():S4-7. PubMed ID: 1960378
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
[TBL] [Abstract][Full Text] [Related]
20. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials.
Dusheiko GM; Paterson AC; Pitcher L; Kassianides C; DiBisceglie AM; Song E; Kew MC
J Hepatol; 1986; 3 Suppl 2():S199-207. PubMed ID: 3298408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
